---
figid: PMC5686390__fimmu-08-01540-g001
figtitle: Mucosal-associated invariant T (MAIT) cell activation
organisms:
- Escherichia coli
- Staphylococcus aureus
- Mycobacterium tuberculosis
- Enterococcus faecalis
- Mycobacterium tuberculosis variant bovis BCG
- Streptococcus pyogenes
- Mycobacterium tuberculosis variant bovis
- Salmonella enterica subsp. enterica serovar Typhi
- Orientia tsutsugamushi
- unidentified influenza virus
- Dengue virus
- Orthomyxoviridae
- Human T-cell leukemia virus type I
- Saccharomyces cerevisiae
- Candida albicans
- Candida albicans 23R
- Homo sapiens
- Mus musculus
- Bos taurus
- NA
organisms_ner:
- Homo sapiens
- Bos taurus
- Mus musculus
- Drosophila melanogaster
pmcid: PMC5686390
filename: fimmu-08-01540-g001.jpg
figlink: /pmc/articles/PMC5686390/figure/F1/
number: F1
caption: Mechanisms of mucosal-associated invariant T (MAIT) cell activation. (A)
  MAIT cells are activated by microbes that utilize a riboflavin biosynthetic pathway
  in an MR1-dependent manner. This activation can be enhanced when infected cells
  produce IL-12 and IL-18. (B) MAIT cells are activated by cytokines (IL-12 and IL-18)
  in an MR1-independent manner. These cytokines can be produced by inflammatory cells
  in non-infectious diseases (B1) or infected cells in viral disease (B2). (C) MAIT
  cells are activated by superantigen (SAg) in a T cell receptor (TCR)β-dependent
  manner (1) and/or cytokine-mediated (2 and 5) pathway, then upregulate inhibitory
  receptors such as lymphocyte-activation gene 3 (LAG-3), and then are anergized (3)
  to subsequent bacterial challenge (4).
papertitle: 'Mucosal-Associated Invariant T Cells: New Insights into Antigen Recognition
  and Activation.'
reftext: Xingxing Xiao, et al. Front Immunol. 2017;8:1540.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.5016363
figid_alias: PMC5686390__F1
figtype: Figure
redirect_from: /figures/PMC5686390__F1
ndex: a8d7db55-df39-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5686390__fimmu-08-01540-g001.html
  '@type': Dataset
  description: Mechanisms of mucosal-associated invariant T (MAIT) cell activation.
    (A) MAIT cells are activated by microbes that utilize a riboflavin biosynthetic
    pathway in an MR1-dependent manner. This activation can be enhanced when infected
    cells produce IL-12 and IL-18. (B) MAIT cells are activated by cytokines (IL-12
    and IL-18) in an MR1-independent manner. These cytokines can be produced by inflammatory
    cells in non-infectious diseases (B1) or infected cells in viral disease (B2).
    (C) MAIT cells are activated by superantigen (SAg) in a T cell receptor (TCR)β-dependent
    manner (1) and/or cytokine-mediated (2 and 5) pathway, then upregulate inhibitory
    receptors such as lymphocyte-activation gene 3 (LAG-3), and then are anergized
    (3) to subsequent bacterial challenge (4).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TLR1
  - TLR2
  - TLR3
  - TLR4
  - TLR5
  - TLR6
  - TLR7
  - TLR8
  - TLR9
  - TLR10
  - B3GNT2
  - B3GNTL1
  - NEUROD1
  - TUBB4B
  - APC
  - PROC
  - IL12A
  - IL12B
  - IL18
  - MR1
  - PNKD
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - IL17A
  - TNF
  - CYREN
  - SAG
  - DMBT1
  - RNF7
  - LAG3
  - LOC505306
  - TARP
  - Hbb-b1
  - B3gnt9
  - Hbb-b2
  - Neurod1
  - Apc
  - Il18
  - Mr1
  - Pnkd
  - Trav6-3
  - Il17a
  - Tnf
  - Cyren
  - Sag
  - Rnf7
  - Lag3
  - 18w
  - tok
  - tlr-2
  - egh
  - LanB1
  - betaTub56D
  - mys
  - Prosbeta1
  - Prosbeta2
  - betaTub85D
  - nAChRbeta2
  - Apc2
  - Axn
  - Fs(3)Apc
  - Tcr
  - egr
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - mri
  - cnk
---
